← Back to home
Comparison · Analytics

DoseFinding vs ymlthis

A side-by-side editorial comparison of DoseFinding and ymlthis — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs ymlthis: at a glance

FeatureDoseFindingymlthis
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingr-markdown, yaml, retirement, quarto
Last editorial update43m ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is ymlthis?

ymlthis retired itself, naming Quarto as the reason it no longer needs to exist.

ymlthis built R Markdown YAML front matter programmatically — a fluent `yml_*()` interface plus RStudio add-ins, so users did not have to hand-write metadata blocks whose valid fields were scattered across output-format documentation. Version 1.0.0 declares the package retired, with only CRAN-preserving changes to follow, and states the reason plainly: Quarto now provides good YAML support.

Read the full ymlthis trajectory →

DoseFinding vs ymlthis: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

Y
ymlthis
ANALYTICS
0.0

ymlthis retired itself, naming Quarto as the reason it no longer needs to exist.

◆ Current state

ymlthis built R Markdown YAML front matter programmatically — a fluent `yml_*()` interface plus RStudio add-ins, so users did not have to hand-write metadata blocks whose valid fields were scattered across output-format documentation. Version 1.0.0 declares the package retired, with only CRAN-preserving changes to follow, and states the reason plainly: Quarto now provides good YAML support.

◆ Where it's heading

The retirement is the endpoint of a long drift. Between 2020 and 2022 every release was reactive — patching around a crayon update that mangled rendered YAML, tracking shiny 1.6, following roxygen2 7.0.0, fixing a typo in an add-in. No new capability has landed in six years, and the four-year gap before 1.0.0 had already answered the question the release note finally makes explicit.

◆ Prediction

Nothing further of substance is expected — the stated policy is changes only where CRAN requires them, so the next release, if any, will be a compatibility patch.

Alternatives to DoseFinding and ymlthis

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or ymlthis.

See all DoseFinding alternatives → · See all ymlthis alternatives →

Recent activity from DoseFinding and ymlthis

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 5mo agoymlthisymlthis retired; Quarto covers the need
  2. 1y agoDoseFindingConditional and predictive power for interim analyses
  3. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  4. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  5. 2y agoDoseFindingCompliance update for R-devel
  6. 3y agoDoseFindingpowMCTBinCount bug fix
  7. 4y agoymlthisTypo fixed in the miniUI add-in check
  8. 4y agoymlthisyml_author() accepts yml_blank(); shiny fixes
  9. 4y agoymlthisciteproc handling moved to newer rmarkdown functions
  10. 5y agoymlthisPatched a crayon update that mangled rendered YAML
  11. 5y agoymlthisAdjustments for shiny 1.6

Frequently asked questions

What is the difference between DoseFinding and ymlthis?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and ymlthis are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than ymlthis?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and ymlthis are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to ymlthis?

Top ymlthis alternatives in Analytics are ranked by recent ship velocity. Browse the "ymlthis alternatives" section above for the current picks, or visit /alternatives/ymlthis for the full list with editorial commentary on each.